Earnings Summary

Spruce Biosciences Inc’s revenue jumped +Inf% since last year same period to $2.17Mn in the Q2 2023. On a quarterly growth basis, Spruce Biosciences Inc has generated 10.23% jump in its revenue since last 3-months.

Spruce Biosciences Inc’s net profit fell -8.02% since last year same period to $-12.82Mn in the Q2 2023. On a quarterly growth basis, Spruce Biosciences Inc has generated -2.48% fall in its net profits since last 3-months.

Spruce Biosciences Inc’s net profit margin jumped NaN% since last year same period to -592.33% in the Q2 2023. On a quarterly growth basis, Spruce Biosciences Inc has generated 7.04% jump in its net profit margins since last 3-months.

Spruce Biosciences Inc’s earning per share (EPS) estimates for the current quarter stand at -0.52 - a 1.89% jump from last quarter’s estimates.

Spruce Biosciences Inc’s earning per share (EPS) estimates for the current year stand at -0.52.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Spruce Biosciences Inc’s return on assets (ROA) stands at -0.28.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Spruce Biosciences Inc’s return on equity (ROE) stands at -0.52.